Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
2.170
+0.030 (1.40%)
At close: Apr 13, 2026, 4:00 PM EDT
2.220
+0.050 (2.30%)
After-hours: Apr 13, 2026, 7:57 PM EDT
CELZ Market Cap
CELZ has a market cap or net worth of $8.02 million as of April 13, 2026. Its market cap has increased by 105.69% in one year.
Market Cap
8.02M
Enterprise Value
827.84K
1-Year Change
105.69%
Ranking
Category
Stock Price
$2.17
Market Cap Chart
Since December 3, 2021, CELZ's market cap has decreased from $16.10M to $8.02M, a decrease of -50.18%. That is a compound annual growth rate of -14.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 7.90M | 54.90% |
| Dec 31, 2025 | 5.10M | 27.50% |
| Dec 31, 2024 | 4.00M | -37.50% |
| Dec 29, 2023 | 6.40M | 18.52% |
| Dec 30, 2022 | 5.40M | -66.46% |
| Dec 31, 2021 | 16.10M | - |
| Dec 3, 2021 | 16.10M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Liminatus Pharma | 8.41M |
| Evogene | 8.30M |
| NuCana | 8.20M |
| Quince Therapeutics | 7.59M |
| TransCode Therapeutics | 7.53M |
| Acurx Pharmaceuticals | 7.45M |
| Aptorum Group | 7.41M |
| BioAtla | 7.39M |